FindTrial
Sign In

The dysregulation of proteases in inflammatory diseases of the skin: Determination of protease activity using a novel neuropeptide assay

The dysregulation of proteases in inflammatory diseases of the skin: Determination of protease activity using a novel neuropeptide assay - DPPA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00018883
Enrollment
30
Registered
2019-10-25
Start date
2019-10-24
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L40.0 M34.0 L20.8 L80

Interventions

Group 1: Psoriasis vulgaris, systemic sclerosis, atopical ekzema, non-segmental vitiligo
sampling of capillary blood from the fingertip and documentation of disease history Group 2: Healthy persons (Questionnaire, blood draw)

Sponsors

Core Unit Proteomics, Universität Münster
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Males between 20 and 40 years of age with psoriasis vulgaris, systemic sclerosis, atopical ekzema, non-segmental vitiligo and healthy controls

Exclusion criteria

Exclusion criteria: all else

Design outcomes

Primary

MeasureTime frame
Bradykinin fragments 1-5 and 1-8 will be measured following 1h incubation—

Countries

Germany

Contacts

Public ContactSimone König

Core Unit Proteomics, Universität Münster

koenigs@uni-muenster.de0251-8357164

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026